Positioning disease-resistance and protective alleles as acceptable ‘enhancement’ to lower ethical and regulatory barriers.
— Blurs therapy–enhancement distinctions, affects insurer coverage, equity debates, and clinical guidelines for elective editing or embryo selection.
Noah Smith
2025.08.17
82% relevant
The article explicitly frames embryo selection to avoid genetic disease as preventing suffering rather than 'eugenics,' which aligns with repositioning protective interventions as acceptable enhancement to lower ethical and regulatory barriers.
Davide Piffer
2025.07.30
100% relevant
The article highlights alleles conferring ‘superhuman’ disease resistance and protective capabilities as central enhancement targets.
← Back to All Ideas